MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41408-020-0329-y

Медицинская библиотека · Blood cancer journal · 2020

Ultra-accurate Duplex Sequencing for the assessment of pretreatment ABL1 kinase domain mutations in Ph+ ALL.

Short Nicholas J, Kantarjian Hagop, Kanagal-Shamanna Rashmi, Sasaki Koji, Ravandi Farhad, Cortes Jorge, Konopleva Marina, Issa Ghayas C, Kornblau Steven M, Garcia-Manero Guillermo, Garris Rebecca, Higgins Jake, Pratt Gabriel, Williams Lindsey N, Valentine Charles C, Rivera Victor M, Pritchard Justin, Salk Jesse J, Radich Jerald, Jabbour Elias

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Mutations of ABL1 are the dominant mechanism of relapse in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL). We performed highly accurate Duplex Sequencing of exons 4-10 of ABL1 on bone marrow or peripheral blood samples from 63 adult patients with previously untreated Ph + ALL who received induction with intensive chemotherapy plus a BCR-ABL1 TKI. We identified ABL1 mutations prior to BCR-ABL1 TKI exposure in 78% of patients. However, these mutations were generally present at extremely low levels (median variant allelic frequency 0.008% [range, 0.004%-3.71%] and did not clonally expand and lead to relapse in any patient, even when the pretreatment mutation was known to confer resistance to the TKI received. In relapse samples harboring a TKI-resistant ABL1 mutation, the corresponding mutation could not be detected pretreatment, despite validated sequencing sensitivity of Duplex Sequencing down to 0.005%. In samples under the selective pressure of ongoing TKI therapy, we detected low-level, emerging resistance mutations up to 5 months prior to relapse. These findings suggest that pretreatment ABL1 mutation assessment should not guide upfront TKI selection in Ph + ALL, although serial testing while on TKI therapy may allow for early detection of clinically actionable resistant clones.

Для цитирования: Short Nicholas J, Kantarjian Hagop, Kanagal-Shamanna Rashmi, Sasaki Koji, Ravandi Farhad, Cortes Jorge, Konopleva Marina, Issa Ghayas C, Kornblau Steven M, Garcia-Manero Guillermo, Garris Rebecca, Higgins Jake, Pratt Gabriel, Williams Lindsey N, Valentine Charles C, Rivera Victor M, Pritchard Justin, Salk Jesse J, Radich Jerald, Jabbour Elias. Ultra-accurate Duplex Sequencing for the assessment of pretreatment ABL1 kinase domain mutations in Ph+ ALL.. Blood cancer journal. 2020. DOI: 10.1038/s41408-020-0329-y.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.